STAT3 and urinary bladder cancer: Using a STAT3 transgenic mouse model, chemical induction of bladder cancer by N-butyl-N-(4-Hydroxybutyl) nitrosamine (BBN) directly resulted in the development of invasive carcinoma from carcinoma in situ, asserting the role of STAT3 in bladder cancer progression [18].